ARTICLE | Clinical News
Neublastin artemin/enovin: Interim Phase I data
June 18, 2012 7:00 AM UTC
Interim data from 16 sciatic patients in a single-blind, placebo-controlled, Dutch Phase I trial showed that multiple doses of IV Neublastin were well tolerated with no treatment-related serious adver...